Pharmacokinetic/pharmacodynamic analysis of continuous-infusion fosfomycin in combination with extended-infusion cefiderocol or continuous-infusion ceftazidime-avibactam in a case series of difficult-to-treat resistant pseudomonas aeruginosa bloodstream infections and/or hospital-acquired pneumonia

HIGHLIGHTS

• who: Milo Gatti et al. from the Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy have published the paper: Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia, in the Journal: Antibiotics 2022, 11, 1739. of 30/06/2022
• what: The aim of this study was to carry out a PK/PD analysis of combination therapy with CI fosfomycin plus EI cefiderocol . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.